Four regions 12-core systemic prostate biopsy for diagnosis of prostate cancer.
- Author:
Rongpei WU
1
;
Keli ZHENG
;
Xiaofei LI
;
Wanmei ZHONG
Author Information
- Publication Type:Journal Article
- MeSH: Aged; Aged, 80 and over; Biopsy, Needle; adverse effects; Humans; Male; Middle Aged; Prostate; pathology; Prostatic Neoplasms; diagnosis; pathology
- From: National Journal of Andrology 2004;10(7):493-495
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the clinical value of the four regions 12-core systemic prostate biopsy.
METHODSNinety-one patients suspected of prostate cancer received four regions 12-core systemic prostate biopsy, and the detection rate and complications were compared with those of the sextant method.
RESULTSMore positive results were obtained in detecting prostate cancer with the four regions 12-core method, and the complications were similar to those of the sextant biopsy.
CONCLUSIONThe four regions 12-core biopsy was suggested for patients suspected of prostate cancer with enlarged prostate gland above 40 ml.
